| Literature DB >> 36261948 |
Miguel Almeida1, Tiago F Rama2, Rui Quintanilha2, Joana Mendes2, Vitor Carneiro3.
Abstract
INTRODUCTION: The widespread use of imaging methods has led to an increased identification of asymptomatic Pancreatic Cystic Lymphangiomas (PCL), a rare entity for which available information is very limited. PRESENTATION OF CASE: We present the case of an asymptomatic 61-year-old male, submitted to elective enucleation of a pancreatic head PCL at our institution. After four years of follow-up the patient is doing well and has no clinical or imaging signs of recurrence. DISCUSSION: Though rare, PCL should be included in the differential diagnosis of pancreatic cystic neoplasms. All efforts should be made to ascertain a preoperative diagnosis, as expectant follow-up could be a reasonable approach in asymptomatic patients and/or poor surgical candidates. In the face of an uncertain diagnosis, complete surgical excision may be the treatment of choice.Entities:
Keywords: Cystic lymphangioma; D2-40; EUS; Incidentaloma; Local excision; Pancreas
Year: 2022 PMID: 36261948 PMCID: PMC9568866 DOI: 10.1016/j.ijscr.2022.107715
Source DB: PubMed Journal: Int J Surg Case Rep ISSN: 2210-2612
Figs. 1Ultrasound showing a polycystic lesion with fine septa, measuring approximately 76 × 63 × 61 mm, without calcifications or vegetations, located between the pancreas and the left liver lobe.
Figs. 2CT abdominal scan (axial, coronal and sagital planes). The nodular cystic lesion located in the head/proximal body of pancreas, with no post contrast enhancement.
Fig. 3Haematoxylin and eosin staining showed that the multicystic lesion was composed of irregular dilated spaces separated by a stroma of connective tissue (with aggregates of mature lymphoid cells), lined by a layer of endothelial cells, (20×, H&E stain).
Fig. 4The endothelial cells showed positive staining for D2–40 (20×, D2–40 immunohistochemistry).
Noninclusive list of differential diagnosis of Pancreatic Cystic Lymphangioma.
| Type of lesion | Classification | Entity | Reference |
|---|---|---|---|
| Nonneoplasic | Pseudocysts | ||
| Ductal ectasia in chronic fibrosing pancreatitis | |||
| Echinococcal cysts of the pancreas | |||
| Polycystic pancreas associated with polycystic kidney disease | |||
| Von Hippel–Lindau syndrome | |||
| Cystic fibrosis | |||
| Renal, pancreatic and hepatic dysplasia sequence | |||
| Lymphoepithelial cyst | |||
| Neoplasic | Serous cystadenomas | ||
| Mesenchymal tumors (e.g. hemangiomas) | |||
| Intraductal papillary mucinous neoplasm | |||
| Mucinous cystic neoplasms | |||
| Cystic adenocarcinomas | |||
| Pancreatic neuroendocrine neoplasms with cystic degeneration | |||
| Acinar cell carcinoma with cystic degeneration | |||
| Pancreatic ductal carcinomas with cystic degeneration |
Typical findings and possible advantages of the different methods of cross-sectional imaging on Pancreatic Cystic Lymphangioma.
| Imaging method | Typical findings and possible advantages | Reference |
|---|---|---|
| Abdominal radiograph | Bowel dislocation or obstruction | |
| US/CT | Well-circumscribed, encapsulated, hypoechoic / water-isodense, uni- or more often multilocular mass with thin septa. | |
| Wall and septa may show enhancement by intravenous contrast medium (CT). | ||
| Rarely, phlebolith-like calcifications can occur in the dilated lymphatic spaces. | ||
| No ascitis or lymphadenopaty. | ||
| No evidence of pancreatic or biliary duct dilation. | ||
| MRI | Well-circumscribed, encapsulated, uni- or more often multilocular mass with thin septa, hyperintense on T2-WI and hypointense on T1-WI | |
| Superiority to CT in defining interfaces with adjacent structures | ||
| Superiority to CT in ruling out communication between cyst and pancreatic duct | ||
| Post‑gadolinium studies have sometimes the advantage of defining the thin septa, when contrast-enhanced CT could not demonstrate. | ||
| 18-FDG-PET/CT | Peripheral, low uptake of the radiotracer, with no sign of metabolic activity into the mass |